Phase II Multicenter, Double-blinded Clinical Trial of SP160412 in the Temporary Relief of Mild to Moderate (i.e,First Degree) Sunburn

Trial Profile

Phase II Multicenter, Double-blinded Clinical Trial of SP160412 in the Temporary Relief of Mild to Moderate (i.e,First Degree) Sunburn

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Apr 2018

At a glance

  • Drugs SP 160412 (Primary) ; Chlorphenamine; Ibuprofen
  • Indications Sunburn
  • Focus Therapeutic Use
  • Sponsors Sephoris Pharmaceuticals
  • Most Recent Events

    • 20 Apr 2018 Status changed from not yet recruiting to recruiting.
    • 01 Dec 2017 Planned End Date changed from 1 Sep 2019 to 1 Nov 2019.
    • 01 Dec 2017 Planned primary completion date changed from 1 Nov 2018 to 1 Jan 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top